| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Sprague John M is a Chief Financial Officer at T2 Biosystems, Inc.. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $0 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | TTOO T2 Biosystems, Inc. | Chief Financial Officer | Sale+OE | 2,693 | $0.62 | $1,681.57 | -17.4% | |
| Apr 8, 2022 | TTOO T2 Biosystems, Inc. | Chief Financial Officer | Buy | 10,000 | $0.48 | $4,767.00 | +7.0% | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | Chief Financial Officer | Sale+OE | 5,250 | $2.04 | $10,710.00 | -12.9% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | Chief Financial Officer | Sale+OE | 4,166 | $0.82 | $3,416.12 | -15.8% |